NCT07060807 2026-03-16
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Merck Sharp & Dohme LLC
Phase 3 Recruiting
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Daiichi Sankyo
Gustave Roussy, Cancer Campus, Grand Paris